Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Oxford, UK - 13 May 2026: OXB (LSE: OXB) (the "Company"), a global quality and innovation-led cell and gene therapy CDMO, today announces that Natalie Walter, Chief Legal Officer and Group Company ...

OXB Secures New Four-Year Term Loan Facility with Oaktree - Up to $125 million Oaktree loan facility to support OXB's global CDMO operations and growth strategy - $60 million upfront to repay existing ...

A cold front may bring late-day thunderstorms to the DMV, some severe with damaging winds, hail and heavy rain. by Winston Rogers OCEAN CITY, Md. (7News) — A small airplane made an emergency landing ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Oxford, UK – 8 May 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the 30 th Annual Meeting of the American Society of Cell ...

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based ...

Things look different! Content is moderated according to our Community Guidelines.

Oxford BioMedica PLC (OXB.LN) said Tuesday that it has entered a research collaboration with Microsoft Corp. (MSFT) to use cloud and machine-learning technology to improve gene and cell therapy ...